Thrivent Financial For Lutherans Alkermes Plc. Transaction History

Thrivent Financial For Lutherans

$51.6 Billion
Q4 2024

A detailed history of Thrivent Financial For Lutherans transactions in Alkermes Plc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 125,066 shares of ALKS stock, worth $4.48 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

125,066

Previous 129,312 3.28%

Holding current value

$4.48 Million

Previous $3.62 Million 0.61%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$25.7 - $31.46 $109,122 - $133,579	-4,246 Reduced 3.28%	125,066 $3.6 Million
Q3 2024 Nov 07, 2024	SELL	$23.01 - $28.55 $256,929 - $318,789	-11,166 Reduced 7.95%	129,312 $3.62 Million
Q2 2024 Aug 13, 2024	SELL	$23.21 - $27.24 $1.63 Million - $1.92 Million	-70,398 Reduced 33.38%	140,478 $3.39 Million
Q1 2024 May 14, 2024	SELL	$26.4 - $32.56 $3.87 Million - $4.77 Million	-146,426 Reduced 40.98%	210,876 $5.71 Million
Q4 2023 Feb 14, 2024	BUY	$23.37 - $28.68 $2.55 Million - $3.13 Million	109,041 Added 43.92%	357,302 $9.91 Million
Q3 2023 Nov 14, 2023	SELL	$27.17 - $31.97 $2.86 Million - $3.36 Million	-105,171 Reduced 29.76%	248,261 $6.95 Million
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $2.95 Million - $3.51 Million	104,235 Added 41.83%	353,432 $11.1 Million
Q4 2022 Feb 08, 2023	SELL	$21.94 - $26.24 $2.41 Million - $2.88 Million	-109,768 Reduced 30.58%	249,197 $6.51 Million
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $7.9 Million - $11.4 Million	358,965 New	358,965 $8.02 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $643,948 - $924,708	-41,842 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$16.16 - $20.66 $887,571 - $1.13 Million	-54,924 Reduced 56.76%	41,842 $694,000
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $585,296 - $951,891	44,816 Added 86.27%	96,766 $1.4 Million
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $898,215 - $1.13 Million	51,950 New	51,950 $1.06 Million
Q4 2018 Feb 15, 2019	SELL	$27.94 - $44.61 $191,919 - $306,426	-6,869 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$38.6 - $46.12 $265,143 - $316,798	6,869 New	6,869 $292,000

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.89B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Alkermes Plc. Transaction History